News & Updates
Filter by Specialty:
Pharmacist-led smoking cessation program prompts quit attempts, IBD medication use
A smoking cessation program led by a pharmacist in a specialty medical home is feasible and may even lead to successful quit attempts and improved use of inflammatory bowel disease (IBD) medications, suggest the results of a study.
Pharmacist-led smoking cessation program prompts quit attempts, IBD medication use
04 Dec 2022
Post-PCI bivalirudin infusion reduces death, bleeding vs heparin
Patients with ST-elevation myocardial infarction (STEMI) who undergo primary percutaneous coronary intervention (PCI) have a reduced risk of all-cause death or BARC* type 3–5 bleeding when they receive a bolus plus post-PCI high-dose infusion of bivalirudin compared with heparin monotherapy, results of the BRIGHT**-4 trial showed.
Post-PCI bivalirudin infusion reduces death, bleeding vs heparin
04 Dec 2022
Group CBT may help improve emotion regulation in adults with autism
Among adults with autism spectrum disorder (ASD), group-based cognitive behavioural therapy (CBT) appears to yield modest improvements in emotion regulation, a recent study has found.
Group CBT may help improve emotion regulation in adults with autism
04 Dec 2022
HCV, HBV coinfection does not compromise HIV prognosis in the presence of active ART
Among people living with HIV on active antiretroviral therapy (ART), coinfection with the hepatitis B (HBV) or hepatitis C (HCV) viruses does not seem to significantly worsen immunologic and virologic response to treatment, a recent study has found.
HCV, HBV coinfection does not compromise HIV prognosis in the presence of active ART
04 Dec 2022
Mindfulness programme as effective as escitalopram in treating anxiety
Mindfulness-based stress reduction (MBSR) course is safe and as effective as first-line escitalopram for treatment of anxiety disorders, a randomized control trial has shown.
Mindfulness programme as effective as escitalopram in treating anxiety
04 Dec 2022
Fatty liver more common in MAFLD than NAFLD
Patients with metabolic dysfunction-associated fatty liver disease (MAFLD) see higher rates of fatty liver than those with nonalcoholic fatty liver disease (NAFLD), a recent study has found.
